• Member Login
  • Become a Member
  • Database Search
IATI - Israel Advanced Technology Industries
IATI - Israel Advanced Technology Industries
IATI Database Life Science Companies Pharmaceuticals New Chemical Entity

New Chemical Entity

  out of 25 items.

  • Ayala Pharmaceuticals
    Targeted therapy oncology company
  • BioLineRx
    BioLineRx (NASDAQ: BLRX; TASE: BLRX) is a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising...
  • Bsense Bio Therapeutics Ltd.
    Bsense Bio Therapeutics is developing small molecules for the treatment of neuropathic pain. Bsense is pioneering a novel approach targeting...
  • Concenter BioPharma
    Developing Novel Drugs (New Chemical Entities) for Treating and Preventing Type 2 Diabetes, Psoriasis and IBD…now entering...
  • Ela Pharma
    Elapharma is developing a new drug based on small Molecule for the inhibition of necrosis. Necrosis is the main mode of cell death and is associated...
  • Novaremed Ltd
    A clinical stage pharmaceutical company developing a NCE for the treatment of neuropathic pain associated with diabetes.
  • Pi Therapeutics Ltd
    Pre-clinical stage oncology company developing first-in-class small molecule drugs.  
  • Prilenia Therapeutics
    Prilenia's purpose is to improve the lives of patients and their families by developing treatments for neurodegenerative and neurodevelopmental...
  • Regenera Pharma Ltd.
    At Regenera, we aspire to change the devastating inevitability of long-term damage to the central nervous system. Our lead product, RPh201, is...
  • Tarsius Pharma
    ...
  • Vidac Pharma Ltd.
    Vidac Pharma is a clinical-stage biopharmaceutical company dedicated to discovering and developing first-in-class medicines to help people suffering...
  • Avraham Pharmaceuticals
    Avraham Pharmaceuticals, a privately held company, founded in 2010,  develops its multi-functional drug ladostigil for mild cognitive impairment...
  • BioRest Ltd.
    BioRest is developing a new therapy that directly targets proliferative monocytes with a liposome-housed bisphosphonate that can more effectively...
  • BioSight
    BioSight is a private biopharmaceutical company focused on research and development of innovative cancer targeted pro-drugs. BioSight has...
  • D-Pharm Ltd
    D-Pharm (TASE: DPRM) is a drug-development company focused on innovative drugs for the treatment of central nervous system (CNS) conditions....
  • Metallo Therapy
    Metallo-Therapy is an early stage company focusing on improving cancer diagnostics and treatment. The Company specializes in developing products...
  • Neurim Pharmaceuticals (1991) Ltd.
    Neurim Pharmaeuticals is a drug discovery and development company focusing on CNS , particularly on diseases that are associated with sleep...
  • NovoTyr Therapeutics Ltd.
    NovoTyr discovered a novel proprietary family of small Mw inhibitors with unique mechanism, gaining long lasting anti-tumor effect. NovoTyr...
  • Q2 Pharma Ltd.
    Q2Pharma specializes in developing small-molecule drugs against multi-drug resistant (MDR) bacteria to be used in conjunction with commonly used...
  • Se-cure Pharmaceuticals ltd.
    Se-cure is a clinical stage & revenue generating, research-driven Israeli Pharmaceutical company, which has developed a proprietary platform...
  out of 25 items.
| Terms of Use | Privacy Policy | Sitemap